‘Beezin’: teens applying lip balm to eyelids to experience buzz

Article

According to a report from a television station in Cincinnati, OH, some teenagers are now applying Burt’s Bees lip balm onto the outside of their eyelids to enhance intoxication from alcohol or other drugs. They call it “beezin.”

 

According to a report from a television station in Cincinnati, OH, some teenagers are now applying Burt’s Bees lip balm onto the outside of their eyelids to enhance intoxication from alcohol or other drugs. They call it “beezin.”

Some speculate that the teens are experiencing a tingling or burning sensation from the lip balm’s peppermint oil, which the teens are claiming feels good when they are intoxicated. But the peppermint oil can also be a strong irritant to the eye.

“The search for a ‘natural high,’ becomes a perfect set up for a Type IV hypersensitivity reaction,” says Optometry Times Editorial Advisory Board member Milton Hom, OD, FAAO, FACAAI (Sc). “A nice buzz initially can later develop into a full-blown inflammatory response requiring treatment.”

New Jersey allergist Leonard Bielory says he routinely sees patients with these types of reactions. “Interestingly, this and other ‘natural products’ are very common sensitizers and can cause a contact dermatitis, especially the area around the eyes which is especially sensitive to minor inflammatory changes.”

YouTube videos of the trend date back to last year-including a teen appearing to “beez” at a school-and have tens of thousands of views.

Moral of the story: don’t try this at home, kids. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
© 2025 MJH Life Sciences

All rights reserved.